Explore
Search
Learn
Watch
Portfolio
CTNM
Contineum Therapeutics, Inc.
Healthcare
$8.29
-25%
1Y
$8.29
$7.09
52 weeks
$17.56
CTNM
Contineum Therapeutics, Inc.
$8.29
-24.84%
1Y
Overview
Safety
Valuation
Market
Financials
Ownership
Who owns it
opening the register…
More on Contineum Therapeutics, Inc.
CTNM overview
Price, RyuScore, the earnings flow and the five questions at a glance.
CTNM revenue and segments
The quarter as a flow, the full statements, and what the business is made of.
CTNM financial charts
Every reported figure as its own chart, quarterly and trailing twelve months.
Is CTNM financially safe?
Distress and accounting checks, debt cover, drawdowns and factor exposure.
Is CTNM overvalued?
What the price assumes, its own history, peer multiples and a fair-value range.
CTNM price history
Trend and momentum, key levels, total return, seasonality.
CTNM SEC filings and events
The company's own record, every flag beside its market-wide base rate.
Biotechnology
The closest names by size in the same industry
Compare peers
Random peer
AGMB
-2.3%
Agomab Therapeutics NV
TTRX
+1.1%
Turn Therapeutics Inc.
ZURA
-4.5%
Zura Bio Ltd
BNTC
-2.0%
Benitec Biopharma Inc.
AVIR
0.00%
Atea Pharmaceuticals, Inc.
SRZN
-1.0%
Surrozen, Inc.